SCHEMBL31301121

SCHEMBL31301121

CCCCCCC[NH3+].[Sn+4]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL7705428 0.97 DNM1 (0.87)
Iodide SCHEMBL7698983 0.97 DNM1 (0.87)
Dodecylamine SCHEMBL7697638 0.97 DNM1 (0.87)
Dodecylamine SCHEMBL1426383 0.93 DNM1 (0.93)
Tetradecylamine SCHEMBL11856039 0.93 DNM1 (0.93)
Dodecylamine SCHEMBL7359047 0.93 DNM1 (0.93)
Iodide SCHEMBL18662005 0.90
Dodecylamine SCHEMBL7697639 0.90 DNM1 (0.87)
Hexadecylamine SCHEMBL20597945 0.90 DNM1 (0.87)
Bromide SCHEMBL18662008 0.90 DNM1 (0.87)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727992-A1 AEM ROLL-TO-ROLL INK FORMULATIONS AND PROCESSES FOR CO2 ELECTROLYZERS Twelve Benefit Corporation (US) 2026-04-22 EP disclosed
WO-2024259024-A1 AEM ROLL-TO-ROLL INK FORMULATIONS AND PROCESSES FOR CO2 ELECTROLYZERS TWELVE BENEFIT CORPORATION (US) 2024-12-19 WO disclosed